• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mucoadhesive nanoformulations and their potential for combating COVID-19.

作者信息

Prasher Parteek, Sharma Mousmee

机构信息

UGC Sponsored Centre for Advanced Studies, Department of Chemistry, Guru Nanak Dev University, Amritsar, 143005, India.

Department of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun, 248007, India.

出版信息

Nanomedicine (Lond). 2021 Dec;16(28):2497-2501. doi: 10.2217/nnm-2021-0287. Epub 2021 Nov 3.

DOI:10.2217/nnm-2021-0287
PMID:34730403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8577509/
Abstract
摘要

相似文献

1
Mucoadhesive nanoformulations and their potential for combating COVID-19.黏膜黏附纳米制剂及其对抗COVID-19的潜力。
Nanomedicine (Lond). 2021 Dec;16(28):2497-2501. doi: 10.2217/nnm-2021-0287. Epub 2021 Nov 3.
2
Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2.利用 SARS-CoV-2 的生物学和化学特性了解和抗击 COVID-19。
Bioprocess Biosyst Eng. 2022 Nov;45(11):1753-1769. doi: 10.1007/s00449-022-02788-8. Epub 2022 Sep 20.
3
SARS-CoV-2 Induces Expression of Cytokine and MUC5AC/5B in Human Nasal Epithelial Cell through ACE 2 Receptor.SARS-CoV-2 通过 ACE2 受体诱导人鼻腔上皮细胞中细胞因子和 MUC5AC/5B 的表达。
Biomed Res Int. 2022 Jun 2;2022:2743046. doi: 10.1155/2022/2743046. eCollection 2022.
4
Epidemiology, Transmission, and Molecular Immunopathology of SARS-CoV-2.SARS-CoV-2 的流行病学、传播和分子免疫病理学。
Adv Exp Med Biol. 2021;1352:33-44. doi: 10.1007/978-3-030-85109-5_3.
5
Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice.研发一种新型肽，以防止 SARS-CoV-2 进入表达 hACE2 的肺和嗅球细胞的小鼠。
Mol Brain. 2022 Aug 9;15(1):71. doi: 10.1186/s13041-022-00956-1.
6
Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19.一氧化氮及其衍生物的鼻腔喷雾剂和吸入疗法用于治疗新冠肺炎。
Curr Pharm Des. 2022;28(46):3658-3670. doi: 10.2174/1381612829666221024124848.
7
Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection.刺突介导的 ACE2 下调参与了 SARS-CoV-2 感染的发病机制。
J Infect. 2022 Oct;85(4):418-427. doi: 10.1016/j.jinf.2022.06.030. Epub 2022 Jul 3.
8
Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.没食子儿茶素没食子酸酯 (EGCG) 通过阻断严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 刺突蛋白受体结合域与人血管紧张素转换酶 2 的相互作用来减轻严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染。
PLoS One. 2022 Jul 13;17(7):e0271112. doi: 10.1371/journal.pone.0271112. eCollection 2022.
9
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.血管紧张素转换酶 2 的器官保护作用及其对 COVID-19 预后的影响。
J Med Virol. 2020 Jul;92(7):726-730. doi: 10.1002/jmv.25785. Epub 2020 Apr 5.
10
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.

引用本文的文献

1
Development of an Antiviral Ion-Activated In Situ Gel Containing 18β-Glycyrrhetinic Acid: A Promising Alternative against Respiratory Syncytial Virus.含18β-甘草次酸的抗病毒离子激活原位凝胶的研制：对抗呼吸道合胞病毒的一种有前景的替代方法
Pharmaceutics. 2023 Jul 31;15(8):2055. doi: 10.3390/pharmaceutics15082055.
2
Recent advances in respiratory immunization: A focus on COVID-19 vaccines.呼吸免疫接种的最新进展：重点关注 COVID-19 疫苗。
J Control Release. 2023 Mar;355:655-674. doi: 10.1016/j.jconrel.2023.02.011. Epub 2023 Feb 17.
3
Serum Proteome Signatures of Anti-SARS-CoV-2 Vaccinated Healthcare Workers in Greece Associated with Their Prior Infection Status.血清蛋白质组学特征与希腊接受过 SARS-CoV-2 疫苗接种的医护人员的既往感染状况相关。
Int J Mol Sci. 2022 Sep 5;23(17):10153. doi: 10.3390/ijms231710153.
4
Mucosomes: Intrinsically Mucoadhesive Glycosylated Mucin Nanoparticles as Multi-Drug Delivery Platform.黏着糖基化黏蛋白纳米囊泡（Mucosomes）：作为多药物递送平台的固有黏附性糖基化黏蛋白纳米颗粒。
Adv Healthc Mater. 2022 Aug;11(15):e2200340. doi: 10.1002/adhm.202200340. Epub 2022 Jun 4.
5
Targeting mucin hypersecretion in COVID-19 therapy.针对新冠病毒疾病治疗中的粘蛋白过度分泌问题
Future Med Chem. 2022 May;14(10):681-684. doi: 10.4155/fmc-2021-0111. Epub 2022 Mar 22.

本文引用的文献

1
Low Acyl Gellan as an Excipient to Improve the Sprayability and Mucoadhesion of Iota Carrageenan in a Nasal Spray to Prevent Infection With SARS-CoV-2.低酰基结冷胶作为一种辅料，用于改善鼻喷雾剂中iota角叉菜胶的喷雾性和粘膜粘附性，以预防SARS-CoV-2感染。
Front Med Technol. 2021 Jun 16;3:687681. doi: 10.3389/fmedt.2021.687681. eCollection 2021.
2
Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2.鼻内给药RBD纳米颗粒可诱导针对SARS-CoV-2的黏膜和全身免疫。
Vaccines (Basel). 2021 Jul 9;9(7):768. doi: 10.3390/vaccines9070768.
3
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management.用于 SARS-CoV-2 的鼻内疫苗：在 COVID-19 管理方面的挑战与潜力。
Drug Discov Today. 2021 Nov;26(11):2619-2636. doi: 10.1016/j.drudis.2021.07.021. Epub 2021 Jul 29.
4
Inhalable nanocatchers for SARS-CoV-2 inhibition.吸入式纳米捕集器抑制 SARS-CoV-2。
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29). doi: 10.1073/pnas.2102957118. Epub 2021 Jul 2.
5
Targeted delivery of flufenamic acid by V-amylose.通过 V-淀粉酸靶向递送氟芬那酸。
Ther Deliv. 2021 Aug;12(8):575-582. doi: 10.4155/tde-2021-0020. Epub 2021 Jun 24.
6
Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections.水滑石-氯硝柳胺纳米杂化物作为针对SARS-CoV-2病毒感染的口服制剂
Pharmaceuticals (Basel). 2021 May 19;14(5):486. doi: 10.3390/ph14050486.
7
Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2.制定一种复合鼻腔喷雾剂，可增强 SARS-CoV-2 的表面覆盖率并预防其感染。
Adv Mater. 2021 Jul;33(26):e2008304. doi: 10.1002/adma.202008304. Epub 2021 May 31.
8
Niclosamide-Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment.负载于非离子聚合物包衣黏土插层物中的氯硝柳胺用于增强对COVID-19治疗的生物利用度
Polymers (Basel). 2021 Mar 26;13(7):1044. doi: 10.3390/polym13071044.
9
Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms.新冠病毒肺炎中的细胞因子风暴与黏液高分泌：机制综述
J Inflamm Res. 2021 Jan 22;14:175-189. doi: 10.2147/JIR.S271292. eCollection 2021.
10
Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.避免陷入困境：克服黏液屏障以改善局部药物递送。
Trends Mol Med. 2021 May;27(5):436-450. doi: 10.1016/j.molmed.2020.12.001. Epub 2021 Jan 4.